Since its founding in 1824, the Medical University of South Carolina (MUSC) has grown into one of the nation’s preeminent academic health science centers, with a nationally recognized clinical enterprise, MUSC Health, and six colleges that train approximately 2600 health care professionals each year.
In 2013, U.S. News & World Report recognized MUSC Health as “One of America’s Best Hospitals,” with six specialty areas ranked in the top 50 in the nation, three of them adult (Rheumatology, Ear Nose and Throat, and Nephrology) and three pediatric (Cardiology and Heart Surgery, Gastroenterology and Gastrointestinal Surgery, and Nephrology). Ten other specialty programs were recognized as among the top 25% in the nation. The MUSC Hollings Cancer Center is one of fewer than 70 National Cancer Institute–designated cancer centers in the nation. MUSC’s Institute of Psychiatry has been named South Carolina Hospital of the Year by the National Alliance on Mental Health four of the past five times the award was given.
As a tertiary care center, MUSC Health provides comprehensive care to the most complex of patients through multidisciplinary teams equipped with the latest technology. All members of the health care team play an integral role in creating a culture of excellence by following evidence-based best practices for quality improvement and patient safety.
Innovation is in MUSC Health’s DNA. We attract top-flight specialists, who not only practice evidence-based medicine but make important contributions to the literature and help write the guidelines that influence care across the nation. MUSC Health is the site of many national clinical trials of new medical devices and pharmaceutical agents, providing patients with access to treatment options that would otherwise be unavailable.
MUSC Health is taking the lead in developing the health care technologies and therapies of tomorrow. We value curiosity, encouraging physicians to take clinical questions and dilemmas to biomedical researchers on campus to help devise solutions. This close collaboration between clinicians and investigators helps focus and direct research, speeding the translation of innovation into care. The recently completed James E. Clyburn Research Center, which includes a Drug Discovery Building and a Bioengineering Building and houses robust cores in genomics and drug metabolism (among many others), supports these efforts to develop the therapies of tomorrow.
Patrick J. Cawley CEO, MUSC Health and Vice President for Health Affairs, University